PDL BioPharma 1Q net loss widens
SAN FRANCISCO, May 09, 2008 (Thomson Financial via COMTEX) -- By Staff Reporter
Company: PDL BioPharma Inc (PDLI)
PDL BioPharma Inc. late Thursday reported a first-quarter net loss of $61.9 million, or 42 cents a share, compared with a net loss of $10.6 million, or 9 cents a share, in the year-ago period.
Income from continuing operations was $29.6 million, or 25 cents a share, compared with $216,000, or breakeven a share, in the comparable 2007 period.
The mean estimate of analysts polled by Thomson Reuters was a per-share profit of 8 cents a share.
Revenue for the quarter ended March 31 fell to $57.3 million from $58.9 million a year earlier, versus the mean Street view of $67 million.
The company sees 2008 royalty revenue of $240 million to $260 million.
The stock closed the regular session down 23 cents at $9.45. Brigid Gaffikin bg/gm
COPYRIGHT
Copyright Thomson Financial News Limited 2007. All rights reserved. The copying, republication or redistribution of Thomson Financial News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Financial News.
MMMM
Copyright (C) 2008 Xinhua Financial News. All rights reserved
News Provided by COMTEX
Company: PDL BioPharma Inc (PDLI)
